Acute Leukemia CPG Mini Module - Sequencing Therapies for Acute Leukemia

The SITC Cancer Immunotherapy Guidelines Webinars connect clinicians with leading experts in the field and provide education about the evidence- and consensus-based recommendations in the clinical practice guidelines. To complement the advanced live webinar series, three on-demand, mini modules will assist learners in applying lessons learned on specific topics within the use of immunotherapy in their own practices and locate additional resources to continue their education.   

Mark R. Litzow, MD - Mayo Clinic Cancer Center, summarizes the sequencing of therapies when treating acute leukemia, with an emphasis on acute lymphocytic leukemia.  Data from clinical trials that contributed to the development of the guidelines are discussed, as well as emerging results from ongoing trials.  The role of hematopoietic cell transplant in the context of immunotherapy is also addressed.  

Run time: 9 minutes 25 seconds

Target Audience 

Clinicians and advanced practice providers who treat cancer patients are the target audience, including community physicians, oncologists, emergency room physicians, disease specialists, registered nurses, nurse practitioners, pharmacists, physician assistants and radiologists. 

SITC Online Education Disclaimer 

A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity. 

The Quick Education Modules are part of the Cancer Immunotherapy Clinical Practice Guidelines Advanced Webinar Series supported, in part, by grants from Amgen and Merck & Co., Inc. (as of 9/20/2021). 
 
The SITC Clinical Practice Guidelines are produced and funded solely by SITC. No outside funding is received for the development of the manuscripts.